Effects of therapeutic plasma exchange on serum immunoglobulin concentrations in a dog with refractory immune-mediated hemolytic anemia

Alyssa M. Scagnelli Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Alyssa M. Scagnelli in
Current site
Google Scholar
PubMed
Close
 DVM
,
Stuart A. Walton Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Stuart A. Walton in
Current site
Google Scholar
PubMed
Close
 BVSc
,
Chin-Chi Liu Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Chin-Chi Liu in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Mark J. Acierno Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Mark J. Acierno in
Current site
Google Scholar
PubMed
Close
 DVM, MBA

Abstract

CASE DESCRIPTION A 9-year-old 8.3-kg (18.3-lb) neutered male Miniature Schnauzer was referred for diagnosis and treatment of a sudden onset of lethargy, anorexia, vomiting, and pallor.

CLINICAL FINDINGS On physical examination, the dog was lethargic with pale mucous membranes and a capillary refill time ≥ 2 seconds. Skin and sclera were mildly icteric. Signs of pain were elicited during abdominal palpation, and an enlarged spleen was noted. Results of agglutination testing and cytologic findings were consistent with immune-mediated hemolytic anemia (IMHA). No contributing factors for development of IMHA were identified.

TREATMENT AND OUTCOME Initial treatment included management with immunosuppressant medications. Three packed RBC transfusions were administered, but clinical signs continued to progress. Therefore, therapeutic plasma exchange (TPE) was performed 5 and 9 days after admission. Following each TPE procedure, the dog had an appreciable clinical improvement and decrease in RBC autoagglutination, and the Hct stabilized. Serum IgG and IgM concentrations were measured during and after both TPE procedures. Despite anticoagulative treatment, the dog developed a thrombus in the splenic vein, necessitating a splenectomy.

CLINICAL RELEVANCE The decrease and rebound in serum IgG and IgM concentrations following TPE provided evidence that TPE may have the same immunomodulatory effects in dogs as have been proposed to occur in people. Further, findings suggested that TPE may be a useful alternative in dogs with refractory IMHA when traditional treatments fail.

Abstract

CASE DESCRIPTION A 9-year-old 8.3-kg (18.3-lb) neutered male Miniature Schnauzer was referred for diagnosis and treatment of a sudden onset of lethargy, anorexia, vomiting, and pallor.

CLINICAL FINDINGS On physical examination, the dog was lethargic with pale mucous membranes and a capillary refill time ≥ 2 seconds. Skin and sclera were mildly icteric. Signs of pain were elicited during abdominal palpation, and an enlarged spleen was noted. Results of agglutination testing and cytologic findings were consistent with immune-mediated hemolytic anemia (IMHA). No contributing factors for development of IMHA were identified.

TREATMENT AND OUTCOME Initial treatment included management with immunosuppressant medications. Three packed RBC transfusions were administered, but clinical signs continued to progress. Therefore, therapeutic plasma exchange (TPE) was performed 5 and 9 days after admission. Following each TPE procedure, the dog had an appreciable clinical improvement and decrease in RBC autoagglutination, and the Hct stabilized. Serum IgG and IgM concentrations were measured during and after both TPE procedures. Despite anticoagulative treatment, the dog developed a thrombus in the splenic vein, necessitating a splenectomy.

CLINICAL RELEVANCE The decrease and rebound in serum IgG and IgM concentrations following TPE provided evidence that TPE may have the same immunomodulatory effects in dogs as have been proposed to occur in people. Further, findings suggested that TPE may be a useful alternative in dogs with refractory IMHA when traditional treatments fail.

Contributor Notes

Dr. Scagnelli's present address is Avian & Exotic Animal Clinic of Arizona, 1911 S Lindsay Rd, Mesa, AZ 85204.

Dr. Walton's present address is Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32608.

Dr. Acierno's present address is Department of Medicine, School of Veterinary Medicine, Midwestern University, Glendale, AZ 85308.

Address correspondence to Dr. Acierno (macier@midwestern.edu).
  • 1. Kaplan AA. Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis 2008;52:11801196.

  • 2. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: complications and management. Am J Kidney Dis 1994;23:817827.

  • 3. Winters JL. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematology Am Soc Hematol Educ Program 2012;2012:712.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4. Cohn LA, Kerl ME, Lenox CE, et al. Response of healthy dogs to infusions of human serum albumin. Am J Vet Res 2007;68:657663.

  • 5. Glover PA, Rudloff E, Kirby R. Hydroxyethyl starch: a review of pharmacokinetics, pharmacodynamics, current products, and potential clinical risks, benefits, and use. J Vet Emerg Crit Care (San Antonio) 2014;24:642661.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6. Crump KL, Seshadri R. Use of therapeutic plasmapheresis in a case of canine immune-mediated hemolytic anemia. J Vet Emerg Crit Care (San Antonio) 2009;19:375380.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Acierno MJ, Maeckelbergh V. Continuous renal replacement therapy. Compend Contin Educ Vet 2008;30:264272.

  • 8. von Baeyer H. Plasmapheresis in immune hematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience. Ther Apher Dial 2003;7:127140.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9. Carter CE, Benador NM. Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013. Pediatr Nephrol 2014;29:3550.

  • 10. Malchesky PS. Therapeutic apheresis: why? Ther Apher Dial 2015;19:417426.

  • 11. McDaneld LM, Fields JD, Bourdette DN, et al. Immunomodulatory therapies in neurologic critical care. Neurocrit Care 2010;12:132143.

  • 12. Nenov VD, Marinov P, Sabeva J, et al. Current applications of plasmapheresis in clinical toxicology. Nephrol Dial Transplant 2003;18(suppl 5):v56-v58.

    • Search Google Scholar
    • Export Citation
  • 13. Siami GA, Siami FS. Membrane plasmapheresis in the United States: a review over the last 20 years. Ther Apher 2001;5:315320.

  • 14. Reverberi R, Reverberi L. Removal kinetics of therapeutic apheresis. Blood Transfus 2007;5:164174.

  • 15. Williams ME, Balogun RA. Mini-review principles of separation: indications and therapeutic targets for plasma exchange. Clin J Am Soc Nephrol 2014;9:181190.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16. Terman DS, Gacia-Rinaldi R, Dannemann B, et al. Specific suppression of antibody rebound after extracorporeal immunoadsorption. Clin Exp Immunol 1978;34:3241.

    • Search Google Scholar
    • Export Citation
  • 17. Bartges JW, Klausner JS, Bostwick EF, et al. Clinical remission following plasmapheresis and corticosteroid treatment in a dog with acquired myasthenia gravis. J Am Vet Med Assoc 1990;196:12761278.

    • Search Google Scholar
    • Export Citation
  • 18. Whitley NT, Day MJ. Immunomodulatory drugs and their application to the management of canine immune-mediated disease. J Small Anim Pract 2011;52:7085.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Matus RE, Gordon BR, Leifer CE, et al. Plasmapheresis in five dogs with systemic immune-mediated disease. J Am Vet Med Assoc 1985;187:595599.

    • Search Google Scholar
    • Export Citation
  • 20. Matus RE, Schrader LA, Leifer CE, et al. Plasmapheresis as adjuvant therapy for autoimmune hemolytic anemia in two dogs. J Am Vet Med Assoc 1985;186:691693.

    • Search Google Scholar
    • Export Citation

Advertisement